News | Radiology Imaging | February 24, 2016

Frost & Sullivan Awards Carestream for Medical Imaging Innovation in North America

Company recognized for new product launches across multiple markets, including ultrasound and fluoroscopy

Carestream, Frost & Sullivan Award, new product innovation, medical imaging, North America

February 24, 2016 — Frost & Sullivan has awarded Carestream Health its 2016 North America Frost & Sullivan Award for New Product Innovation Leadership. Carestream was recognized for innovation focused on value-based imaging that solves real-life problems and addresses unmet customer needs.

The award focuses on all aspects of the company’s digital medical imaging portfolio which includes new fluoroscopy and ultrasound systems; new cone-beam computed tomography (CBCT) technology; and a vendor-neutral enterprise imaging Clinical Collaboration Platform.

“A result of Carestream’s commitment to innovation is its latest flagship digital radiography (DR) product, developed using proven, in-house detector technology,” said Frost & Sullivan Industry Principal Nadim Michel Daher. “This next-generation product builds off of its predecessor, the first-of-its-kind ‘DR retrofit’ offerings. It supports a higher level of workflow productivity, dose efficiency and image quality, without requiring heavy investments.”

Carestream is set to replicate the success of its DR systems in the fluoroscopy department with the launch of the DRX-Excel Plus, its multipurpose fluoroscopy/radiography equipment. This device was developed in response to the relative lack of product and technology innovation in this specialty area. It enables healthcare providers to share flat-panel detectors among multiple radiography and fluoroscopy rooms and systems.

Similarly, Carestream recently entered into the ultrasound modality with the Touch Prime and Touch Prime XE premium ultrasound imaging systems. The all-touch control panel is extremely easy to clean and offers tactile feedback on home keys so that operators can stay focused on the patient. The user interface also can be customized to the preferences of the sonographer.

The Touch Prime and Touch Prime XE systems are positioned as the first two models of a new generation of ultrasound systems from Carestream. The product line has a scalable, high-performance platform, which promotes both technology migration as well as transducer migration. These systems provide an ideal entry point for Carestream into the ultrasound space, setting the stage for gradual percolation down to the mid-range and point-of-care ultrasound market.

Carestream’s vision to continually advance the medical imaging marketplace through new technology can be seen in the design of its investigational cone-beam computed tomography (CBCT) system intended for orthopedic imaging. The new technology offers a cost-effective, low-dose, 3-D and weight-bearing imaging technique. When available, the CBCT system will combine the best of two modalities — namely the high-resolution, 3-D imaging capabilities of CT, and the speed, convenience, radiation dose efficiency and affordability of DR.

The company was also recognized for its third-generation, vendor-neutral, standards-based Clinical Collaboration Platform. Its data aggregation and data federation capabilities allow it to integrate additional types of multi-disciplinary and unstructured content into the clinical workflow.

“Complementing its growing portfolio of imaging systems, Carestream’s imaging informatics solution set serves to solidify the company’s overall value proposition to an extended imaging enterprise,” noted Daher. “By continually advancing workflow, data management and reporting solutions to where imaging services are consumed, Carestream has gained a competitive edge with its enterprise imaging IT portfolio.”

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it delivers, which, in turn, increases customer acquisition and overall market penetration potential.

For more information: www.frost.com

Related Content

a) Includes scintigraphy and PET with and without concomitant CT. b) Includes conventional radiography, dual-energy x-ray absorptiometry, fluoroscopy, and radiography performed during radiologic interventions. c) Includes general, cardiothoracic, maxillary, plastic, and orthopedic surgery and neurosurgery. d) Includes allergology, cardiology, geriatrics, general internal medicine, pulmonology, gastroenterology, and rheumatology

a) Includes scintigraphy and PET with and without concomitant CT. b) Includes conventional radiography, dual-energy x-ray absorptiometry, fluoroscopy, and radiography performed during radiologic interventions. c) Includes general, cardiothoracic, maxillary, plastic, and orthopedic surgery and neurosurgery. d) Includes allergology, cardiology, geriatrics, general internal medicine, pulmonology, gastroenterology, and rheumatology. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Radiology Imaging | August 14, 2020
August 14, 2020 — According to ARRS' ...
Videos | Ultrasound Imaging | August 13, 2020
This is a tutorial video on how to perform an ...
There was a higher incidence and severity of physical intimate partner violence (IPV) among patients seen at a large, academic medical center in the U.S. during the COVID-19 pandemic compared with the prior three years, according to new a study published in Radiology.

Getty Images

News | Coronavirus (COVID-19) | August 13, 2020
August 13, 2020 — There was a higher incidence and severity of physical intimate partner violence (IPV) among patient
As healthcare providers and essential personnel work on the front lines of the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) wants clinicians to know that it is here to help through this critical time. Below is a preview of the latest recorded remarks given by FDA Commissioner, Stephen Hahn, M.D.
News | Coronavirus (COVID-19) | August 12, 2020
August 12, 2020 — As healthcare providers and essential personnel work on the front lines of the COVID-19 pandemic, t
GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app. #ASE2020 #AI

GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app.

News | Cardiovascular Ultrasound | August 12, 2020
August 12, 2020 — GE focused on the latest innovations from the handheld ultrasound,...